AON (NYSE:AON) Price Target Raised to $312.00 at Keefe, Bruyette & Woods

AON (NYSE:AON - Free Report) had its target price raised by Keefe, Bruyette & Woods from $294.00 to $312.00 in a report released on Wednesday morning, Benzinga reports. They currently have an underperform rating on the financial services provider's stock.

Other equities research analysts have also issued reports about the stock. Piper Sandler upped their price target on shares of AON from $306.00 to $326.00 and gave the company a neutral rating in a report on Monday, February 12th. BMO Capital Markets lowered their price target on AON from $350.00 to $325.00 and set a market perform rating for the company in a research report on Friday, December 22nd. Royal Bank of Canada reduced their target price on AON from $342.00 to $325.00 and set a sector perform rating on the stock in a research note on Monday, February 5th. Wells Fargo & Company dropped their price target on AON from $304.00 to $295.00 and set an underweight rating for the company in a research note on Thursday, December 21st. Finally, The Goldman Sachs Group cut their target price on shares of AON from $350.00 to $310.00 and set a neutral rating on the stock in a research note on Tuesday, January 9th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and a consensus target price of $337.50.

AON Stock Performance

NYSE:AON traded down $3.40 during trading hours on Wednesday, reaching $316.00. The company's stock had a trading volume of 799,851 shares, compared to its average volume of 1,007,274. The firm has a 50-day simple moving average of $316.61 and a 200-day simple moving average of $315.78. AON has a 1 year low of $284.85 and a 1 year high of $347.37. The firm has a market capitalization of $62.66 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 2.21 and a beta of 0.86.

AON (NYSE:AON - Get Free Report) last issued its earnings results on Friday, February 2nd. The financial services provider reported $3.89 earnings per share for the quarter, missing the consensus estimate of $4.07 by ($0.18). The company had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. AON had a net margin of 19.17% and a negative return on equity of 1,150.40%. The company's revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.89 earnings per share. Equities analysts anticipate that AON will post 15.78 earnings per share for the current fiscal year.

Insider Activity at AON

In related news, Director Lester B. Knight acquired 50,000 shares of the firm's stock in a transaction dated Wednesday, February 7th. The stock was purchased at an average cost of $301.97 per share, with a total value of $15,098,500.00. Following the completion of the acquisition, the director now directly owns 134,000 shares of the company's stock, valued at $40,463,980. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Lester B. Knight acquired 50,000 shares of AON stock in a transaction that occurred on Wednesday, February 7th. The stock was bought at an average price of $301.97 per share, for a total transaction of $15,098,500.00. Following the completion of the transaction, the director now owns 134,000 shares in the company, valued at $40,463,980. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Christa Davies sold 20,618 shares of the firm's stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $311.40, for a total value of $6,420,445.20. Following the completion of the transaction, the chief financial officer now directly owns 159,570 shares in the company, valued at $49,690,098. The disclosure for this sale can be found here. Insiders have sold 74,532 shares of company stock valued at $23,335,805 over the last ninety days. Insiders own 1.15% of the company's stock.

Hedge Funds Weigh In On AON

Institutional investors and hedge funds have recently bought and sold shares of the stock. Arcus Capital Partners LLC grew its stake in shares of AON by 2.7% during the 3rd quarter. Arcus Capital Partners LLC now owns 1,171 shares of the financial services provider's stock valued at $380,000 after acquiring an additional 31 shares during the period. Ronald Blue Trust Inc. boosted its position in shares of AON by 7.4% in the third quarter. Ronald Blue Trust Inc. now owns 450 shares of the financial services provider's stock worth $155,000 after purchasing an additional 31 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of AON by 10.4% in the third quarter. Geneos Wealth Management Inc. now owns 341 shares of the financial services provider's stock worth $111,000 after purchasing an additional 32 shares in the last quarter. Integrated Advisors Network LLC raised its position in shares of AON by 5.1% during the 3rd quarter. Integrated Advisors Network LLC now owns 665 shares of the financial services provider's stock valued at $215,000 after purchasing an additional 32 shares during the period. Finally, Equitable Holdings Inc. lifted its stake in shares of AON by 2.3% during the 1st quarter. Equitable Holdings Inc. now owns 1,447 shares of the financial services provider's stock valued at $456,000 after buying an additional 32 shares in the last quarter. 86.14% of the stock is currently owned by hedge funds and other institutional investors.

AON Company Profile

Aon plc, a professional services firm, provides a range of risk and human capital solutions worldwide. It offers commercial risk solutions, including retail brokerage, specialty solutions, global risk consulting and captives management, and affinity programs; and health solutions, such as health and benefits brokerages, and health care exchanges.